CAS 84676-89-1

Astragaloside II

Description:

Astragaloside II, with the CAS number 84676-89-1, is a natural glycoside primarily derived from the root of Astragalus membranaceus, a plant commonly used in traditional medicine. This compound is characterized by its structural composition, which includes a sugar moiety linked to a steroidal aglycone. Astragaloside II is known for its potential pharmacological properties, including immunomodulatory, anti-inflammatory, and antioxidant effects. It has been studied for its role in enhancing immune function and promoting cellular health. Additionally, research suggests that it may have protective effects against oxidative stress and could support cardiovascular health. The compound is typically soluble in polar solvents, and its stability can be influenced by factors such as pH and temperature. As a bioactive compound, Astragaloside II is of interest in both pharmacological research and herbal medicine, although further studies are needed to fully elucidate its mechanisms of action and therapeutic potential.

Formula: C₄₃H₇₀O₁₅

InChI: InChI=1/C43H70O15/c1-21(45)54-29-28(48)23(47)19-53-34(29)58-43(52)32(49)25(18-44)56-35(33(43)50)55-24-16-26-39(7)17-22(46)30(40(8)13-10-27(57-40)37(4,5)51)38(39,6)14-15-41(26)20-42(41)12-9-11-36(2,3)31(24)42/h22-35,44,46-52H,9-20H2,1-8H3/t22-,23+,24-,25+,26?,27-,28-,29+,30-,31?,32+,33-,34-,35+,38+,39-,40+,41?,42+,43+/m0/s1

InChI key: InChIKey=AYWNHWGQTMCQIV-PENCHUSISA-N

SMILES: C[C@]12[C@]3([C@]4([C@]5(C4)[C@@]([C@@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C3)(C(C)(C)[C@@H](O[C@H]7[C@H](OC(C)=O)[C@@H](O)[C@H](O)CO7)CC5)[H])CC[C@]1(C)[C@]([C@@H](O)C2)([C@]8(C)O[C@H](C(C)(C)O)CC8)[H])[H]

Synonyms:

• (2S,3R,4S,5R)-4,5-dihydroxy-2-{[(2R,3S,4R,5R,6R)-3,4,5-trihydroxy-2-({(1R,2S,3aS,5S,9aR,12aR)-2-hydroxy-1-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl]-3a,6,6,12a-tetramethyltetradecahydro-1H-cyclopenta[a]cyclopropa[e]phenanthren-5-yl}oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}tetrahydro-2H-pyran-3-yl acetate (non-preferred name)
• (3β,6α,16β,20R,24S)-3-[(2-O-Acetyl-β-<span class="text-smallcaps">D</smallcap>-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl β-<smallcap>D</span>-glucopyranoside
• 1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene, β-<span class="text-smallcaps">D</span>-glucopyranoside deriv.
• 9,19-Cyclolanostane, β-<span class="text-smallcaps">D</span>-glucopyranoside deriv.
• Astrasieversianin VIII
• NSC 641295
• astragalosideⅡ
• β-<span class="text-smallcaps">D</smallcap>-Glucopyranoside, (3β,6α,16β,20R,24S)-3-[(2-O-acetyl-β-<smallcap>D</span>-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl
• 1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene, β-D-glucopyranoside deriv.
• (3β,6α,16β,20R,24S)-3-[(2-O-Acetyl-β-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl β-D-glucopyranoside
• Astragaloside II
• 9,19-Cyclolanostane, β-D-glucopyranoside deriv.
• β-D-Glucopyranoside, (3β,6α,16β,20R,24S)-3-[(2-O-acetyl-β-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl
• Astragaloside II
• (3b,6a,16b,20r,24s)-3-((2-o-acetyl-beta-d-xylopyranosyl)oxy)-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl beta-d-glucopyranoside
• Astragaloside II USP/EP/BP
• Cyclosiversioside D
• Astragaloside II 84676-89-1
• Astragaloside II (Astrasieversianin VIII)
• Astragaloside B
• 16,25-dihydroxy-9,19-cyclolanostan-6-yl
• Astragalin Astragaloside II
• Cyclosieversioside D
• ASTRAGALOSIDE II(SH)
• 3-[(2-O-acetyl-β-D-xylopyranosyl)oxy]-20,24-epoxy-

β-​D-​Glucopyranoside, (3β,​6α,​16β,​20R,​24S)​-​3-​[(2-​O-​acetyl-​β-​D-​xylopyranosyl)​oxy]​-​20,​24-​epoxy-​16,​25-​dihydroxy-​9,​19-​cyclolanostan-​6-​yl

CAS: 84676-89-1

Formula: C₄₃H₇₀O₁₅

Purity: 98%

Color and Shape: Solid

Molecular weight: 827.0069

Ref: IN-DA003NXK

Astragaloside II

CAS: 84676-89-1

Astragaloside II

Purity: ≥98%

Molecular weight: 827.01g/mol

Ref: 54-BUP02941

Astragaloside II

CAS: 84676-89-1

Ref: 7W-GC0586

Astragaloside II

CAS: 84676-89-1

Astragaloside II can downregulate the expression of the P-gp and mdr1 gene, suppress phosphorylation of extracellular signal regulated kinase 1/2, p38 and c-Jun N-terminal kinase, suggests that Astragaloside II is a potent multidrug resistance (MDR) reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy.

Formula: C₄₃H₇₀O₁₅

Purity: 95%~99%

Color and Shape: Powder

Molecular weight: 827.018

Ref: BP-BP0211

Astragaloside II

CAS: 84676-89-1

Astragaloside II: Potent for MDR, hepatic cancer therapy; boosts osteogenesis via BMP-2/MAPK, Smad1/5/8 pathways.

Formula: C₄₃H₇₀O₁₅

Purity: 98.54% - 99.7%

Color and Shape: Solid

Molecular weight: 827.01

Ref: TM-T3924

Astragaloside ii

CAS: 84676-89-1

Natural glycoside

Formula: C₄₃H₇₀O₁₅

Purity: ≥ 98.0 % (HPLC)

Color and Shape: Powder

Molecular weight: 827.02

Ref: 5G-89573

Astragaloside II

Controlled Product

CAS: 84676-89-1

Applications Astragaloside II has cardioprotective effects as well as causing improvement in cognitive function. Used in the prevention of cardio-cerebral vascular diseases.
References Shaw, L et al.: PLoS One, 7, e3848 (2012); Kong, X. et al.: Int. J. Mol. Med., 29, 1090 (2012);

Formula: C₄₃H₇₀O₁₅

Color and Shape: Neat

Molecular weight: 827.01

Ref: TR-A790140

Astragaloside II

CAS: 84676-89-1

Astragaloside II is a natural compound that has been shown to have anti-inflammatory effects in vitro and in vivo. Astragaloside II inhibits the production of inflammatory mediators by inhibiting phosphodiesterase and cyclooxygenase pathways. It also has a matrix effect on the cells, which may be due to its ability to activate protein kinase C. This compound also has an analytical method, which consists of HPLC with UV detection at 210 nm.

Formula: C₄₃H₇₀O₁₅

Purity: Min. 95%

Color and Shape: White To Off-White Solid

Molecular weight: 827.01 g/mol

Ref: 3D-MA09407